<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: The length of <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> seems to correlate well with indicators of severe <z:e sem="disease" ids="C0017168" disease_type="Disease or Syndrome" abbrv="GERD">gastro-oesophageal reflux disease</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>However, it remains unknown whether prior acid suppressive therapy affects the length of newly diagnosed <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: A retrospective analysis of a well-characterized large cohort of patients with <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> diagnosed between 1981 and 2000 </plain></SENT>
<SENT sid="3" pm="."><plain>AIM: To compare the length of <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> between patients who received acid suppressive therapy prior to their diagnosis to those who did not receive such therapy </plain></SENT>
<SENT sid="4" pm="."><plain>Pharmacy records were obtained from Department of the Veterans Affairs computerized records and prospectively collected research records </plain></SENT>
<SENT sid="5" pm="."><plain>We further examined the association between prior use of acid suppressive therapy and the length of <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> in correlation analyses, as well as multivariate linear regression analyses while adjusting for differences in year of diagnosis, age, gender, ethnicity, and the presence of <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath> of the gastric cardia </plain></SENT>
<SENT sid="6" pm="."><plain>Results : There were 340 patients with <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> first diagnosed between 1981 and 2000 </plain></SENT>
<SENT sid="7" pm="."><plain>The average length of <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> at the time of first diagnosis was 4.4 cm (range: 0.5-16) </plain></SENT>
<SENT sid="8" pm="."><plain>Of <z:hpo ids='HP_0000001'>all</z:hpo> patients, 139 (41%) had prior use of <z:chebi fb="11" ids="18295">histamine</z:chebi>-2 receptor <z:chebi fb="68" ids="48706">antagonists</z:chebi>, or <z:chebi fb="0" ids="49200">proton-pump inhibitors</z:chebi> (41 used both), and 201 (59%) used neither prior to the diagnosis of <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>The mean length of <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> was significantly shorter in patients with prior use of <z:chebi fb="0" ids="49200">proton-pump inhibitors</z:chebi> (3.4 cm) or <z:chebi fb="0" ids="49200">proton-pump inhibitors</z:chebi> and <z:chebi fb="11" ids="18295">histamine</z:chebi>-2 receptor <z:chebi fb="68" ids="48706">antagonists</z:chebi> (3.1 cm) when compared to those with none of these medications (4.8 cm) </plain></SENT>
<SENT sid="10" pm="."><plain>In the multivariate linear regression model, the prior use of <z:chebi fb="0" ids="49200">proton-pump inhibitors</z:chebi> or either <z:chebi fb="0" ids="49200">proton-pump inhibitors</z:chebi> or <z:chebi fb="11" ids="18295">histamine</z:chebi>-2 receptor <z:chebi fb="68" ids="48706">antagonists</z:chebi> was an independent predictor of shorter length of <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> (P = 0.0396) </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS: The use of acid suppressive therapy among patients is associated with a reduction in the eventual length of newly diagnosed <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> with <z:e sem="disease" ids="C0017168" disease_type="Disease or Syndrome" abbrv="GERD">gastro-oesophageal reflux disease</z:e> </plain></SENT>
<SENT sid="12" pm="."><plain>This finding is independent of the year of diagnosis or demographic features of patients </plain></SENT>
<SENT sid="13" pm="."><plain>Further studies are required to confirm this finding </plain></SENT>
</text></document>